Weighted Correlation Gene Network Analysis Reveals New Potential Mechanisms and Biomarkers in Non-obstructive Azoospermia

Non-obstructive azoospermia (NOA) denotes a severe form of male infertility, whose etiology is still poorly understood. This is mainly due to limited knowledge on the molecular mechanisms that lead to spermatogenesis failure. In this study, we acquired microarray data from GEO DataSets and identifie...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in genetics Vol. 12; p. 617133
Main Authors Dong, Meng, Li, Hao, Zhang, Xue, Tan, Jichun
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 31.03.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Non-obstructive azoospermia (NOA) denotes a severe form of male infertility, whose etiology is still poorly understood. This is mainly due to limited knowledge on the molecular mechanisms that lead to spermatogenesis failure. In this study, we acquired microarray data from GEO DataSets and identified differentially expressed genes using the limma package in R. We identified 1,261 differentially expressed genes between non-obstructive and obstructive azoospermia. Analysis of their possible biological functions and related signaling pathways using the cluster profiler package revealed an enrichment of genes involved in germ cell development, cilium organization, and oocyte meiosis. Immune infiltration analysis indicated that macrophages were the most significant immune component of NOA, cooperating with mast cells and natural killer cells. The weighted gene coexpression network analysis algorithm generated three related functional modules, which correlated closely with clinical parameters derived from histopathological subtypes of NOA. The resulting data enabled the construction of a protein-protein interaction network of these three modules, with CDK1, CDC20, CCNB1, CCNB2, and MAD2L1 identified as hub genes. This study provides the basis for further investigation of the molecular mechanism underlying NOA, as well as indications about potential biomarkers and therapeutic targets of NOA. Finally, using tissues containing different tissue types for differential expression analysis can reflect the expression differences in different tissues to a certain extent. But this difference in expression is only related and not causal. The specific causality needs to be verified later.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
This article was submitted to Genetics of Common and Rare Diseases, a section of the journal Frontiers in Genetics
Edited by: Jordi Pérez-Tur, Institute of Biomedicine of Valencia, Superior Council of Scientific Investigations (CSIC), Spain
Reviewed by: Peter Schlegel, NewYork-Presbyterian, Weill Cornell Medical Center, United States; Jana Emich, University of Münster, Germany
ISSN:1664-8021
1664-8021
DOI:10.3389/fgene.2021.617133